At present, many studies on NAFLD show that AMPK activation can improve the metabolic pathway of the body, especially has an important regulatory effect on lipid metabolism [20, 21]. This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.